Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study.

Falkai P, Malchow B, Wetzestein K, Nowastowski V, Bernstein HG, Steiner J, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitz C, Schmitt A.

Schizophr Bull. 2016 Jul;42 Suppl 1:S4-S12. doi: 10.1093/schbul/sbv157.

PMID:
27460617
2.

Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules.

Cassoli JS, Guest PC, Malchow B, Schmitt A, Falkai P, Martins-de-Souza D.

NPJ Schizophr. 2015 Sep 23;1:15034. doi: 10.1038/npjschz.2015.34. eCollection 2015. Review.

3.

Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior.

Gacias M, Gaspari S, Santos PM, Tamburini S, Andrade M, Zhang F, Shen N, Tolstikov V, Kiebish MA, Dupree JL, Zachariou V, Clemente JC, Casaccia P.

Elife. 2016 Apr 20;5. pii: e13442. doi: 10.7554/eLife.13442.

4.

Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.

Skene NG, Grant SG.

Front Neurosci. 2016 Jan 27;10:16. doi: 10.3389/fnins.2016.00016. eCollection 2016.

5.

Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.

Liu J, Dupree JL, Gacias M, Frawley R, Sikder T, Naik P, Casaccia P.

J Neurosci. 2016 Jan 20;36(3):957-62. doi: 10.1523/JNEUROSCI.3608-15.2016.

6.

A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue.

Elsayed M, Magistretti PJ.

Front Cell Neurosci. 2015 Dec 16;9:468. doi: 10.3389/fncel.2015.00468. eCollection 2015. Review.

7.

Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.

Mauney SA, Pietersen CY, Sonntag KC, Woo TU.

Schizophr Res. 2015 Dec;169(1-3):374-80. doi: 10.1016/j.schres.2015.10.042. Epub 2015 Nov 14.

PMID:
26585218
8.

Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.

Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.

Nutrients. 2015 Oct 22;7(10):8767-82. doi: 10.3390/nu7105427.

9.

Molecular substrates of schizophrenia: homeostatic signaling to connectivity.

Landek-Salgado MA, Faust TE, Sawa A.

Mol Psychiatry. 2016 Jan;21(1):10-28. doi: 10.1038/mp.2015.141. Epub 2015 Sep 22. Review.

10.

Quetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.

Wang HN, Liu GH, Zhang RG, Xue F, Wu D, Chen YC, Peng Y, Peng ZW, Tan QR.

Int J Neuropsychopharmacol. 2015 Aug 1;19(2). pii: pyv088. doi: 10.1093/ijnp/pyv088.

11.

Epigenetic mechanisms in schizophrenia.

Akbarian S.

Dialogues Clin Neurosci. 2014 Sep;16(3):405-17. Review.

12.

Claudin Proteins And Neuronal Function.

Devaux J, Fykkolodziej B, Gow A.

Curr Top Membr. 2010;65:229-253.

13.

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

Steullet P, Cabungcal JH, Monin A, Dwir D, O'Donnell P, Cuenod M, Do KQ.

Schizophr Res. 2016 Sep;176(1):41-51. doi: 10.1016/j.schres.2014.06.021. Epub 2014 Jul 5. Review.

PMID:
25000913
14.

Cerebral white matter abnormalities and their associations with negative but not positive symptoms of schizophrenia.

Asami T, Hyuk Lee S, Bouix S, Rathi Y, Whitford TJ, Niznikiewicz M, Nestor P, McCarley RW, Shenton ME, Kubicki M.

Psychiatry Res. 2014 Apr 30;222(1-2):52-9. doi: 10.1016/j.pscychresns.2014.02.007. Epub 2014 Feb 19.

15.

Afadin regulates puncta adherentia junction formation and presynaptic differentiation in hippocampal neurons.

Toyoshima D, Mandai K, Maruo T, Supriyanto I, Togashi H, Inoue T, Mori M, Takai Y.

PLoS One. 2014 Feb 27;9(2):e89763. doi: 10.1371/journal.pone.0089763. eCollection 2014.

16.

Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities.

Roussos P, Haroutunian V.

Front Cell Neurosci. 2014 Jan 21;8:5. doi: 10.3389/fncel.2014.00005. eCollection 2014. Review.

17.

Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia.

Holleran L, Ahmed M, Anderson-Schmidt H, McFarland J, Emsell L, Leemans A, Scanlon C, Dockery P, McCarthy P, Barker GJ, McDonald C, Cannon DM.

Neuropsychopharmacology. 2014 Mar;39(4):944-54. doi: 10.1038/npp.2013.294. Epub 2013 Oct 22.

18.

Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].

Katsel P, Tan W, Fam P, Purohit DP, Haroutunian V.

PLoS One. 2013 Jul 5;8(7):e68361. doi: 10.1371/journal.pone.0068361. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/59ecb64c-1f53-4d8a-903c-2f835e78bd13.

19.

Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder.

Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, Malhotra AK, Szeszko PR.

Bipolar Disord. 2013 Sep;15(6):680-93. doi: 10.1111/bdi.12096. Epub 2013 Jun 25.

20.

What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia.

Alba-Ferrara LM, de Erausquin GA.

Front Integr Neurosci. 2013 Mar 11;7:9. doi: 10.3389/fnint.2013.00009. eCollection 2013.

Items per page

Supplemental Content

Write to the Help Desk